Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (411-420 of 1,376) with videos related to

Pageof 138
Sort By:
Drug Development Research|September 17, 2016
Improving Current Treatments for SchizophreniaNadja P Maric, Milica J Jovicic, Marina Mihaljevic, et al.
Drug Development Research|September 17, 2016
Lithium Pharmacogenetics: Where Do We Stand?Claudia Pisanu, Carla Melis, Alessio Squassina
Drug Development Research|June 23, 2017
Synergism between Naproxen and Rutin in a Mouse Model of Visceral PainAngel Josabad Alonso-Castro, Joceline Estefanía Rangel-Velázquez, Mario A Isiordia-Espinoza, et al.
Drug Development Research|May 20, 2017
Herbal Formula, Baogan Yihao (BGYH), Prevented Dimethylnitrosamine(DMN)-Induced Liver Injury in RatsXiujie Liu, Jing Su, Yu Shi, et al.
Drug Development Research|May 20, 2017
Anti-Inflammatory and Analgesic Activities of Terminalia Muelleri Benth. (Combretaceae)Nouran M Fahmy, Eman Al-Sayed, Mohamed M Abdel-Daim, et al.
Drug Development Research|July 11, 2018
In silico and in vivo investigation of ferrocene-incorporated acyl ureas and homoleptic cadmium carboxylate derivatives for anticonvulsant, anxiolytic, and sedative potentialSadia Adil, Arif-Ullah Khan, Haroon Badshah, et al.
Drug Development Research|July 11, 2018
Anti-inflammatory and antinociceptive effects of tilifodiolide, isolated from Salvia tiliifolia Vahl (Lamiaceae)Marco Martin González-Chávez, Angel Josabad Alonso-Castro, Juan Ramón Zapata-Morales, et al.
Drug Development Research|August 30, 2016
MicroRNAs as CNS Drug TargetsDavid Gurwitz
Drug Development Research|April 18, 2018
A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitusZhenhai Shang, Feifei Han, Xueyan Zhou, et al.
Drug Development Research|June 30, 2009
EGFR Inhibition in the Treatment of Non-Small Cell Lung CancerDavid E Gerber
Pageof 138

Showing results (411-420 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|September 17, 2016
Improving Current Treatments for SchizophreniaNadja P Maric, Milica J Jovicic, Marina Mihaljevic, et al.
Drug Development Research|September 17, 2016
Lithium Pharmacogenetics: Where Do We Stand?Claudia Pisanu, Carla Melis, Alessio Squassina
Drug Development Research|June 23, 2017
Synergism between Naproxen and Rutin in a Mouse Model of Visceral PainAngel Josabad Alonso-Castro, Joceline Estefanía Rangel-Velázquez, Mario A Isiordia-Espinoza, et al.
Drug Development Research|May 20, 2017
Herbal Formula, Baogan Yihao (BGYH), Prevented Dimethylnitrosamine(DMN)-Induced Liver Injury in RatsXiujie Liu, Jing Su, Yu Shi, et al.
Drug Development Research|May 20, 2017
Anti-Inflammatory and Analgesic Activities of Terminalia Muelleri Benth. (Combretaceae)Nouran M Fahmy, Eman Al-Sayed, Mohamed M Abdel-Daim, et al.
Drug Development Research|July 11, 2018
In silico and in vivo investigation of ferrocene-incorporated acyl ureas and homoleptic cadmium carboxylate derivatives for anticonvulsant, anxiolytic, and sedative potentialSadia Adil, Arif-Ullah Khan, Haroon Badshah, et al.
Drug Development Research|July 11, 2018
Anti-inflammatory and antinociceptive effects of tilifodiolide, isolated from Salvia tiliifolia Vahl (Lamiaceae)Marco Martin González-Chávez, Angel Josabad Alonso-Castro, Juan Ramón Zapata-Morales, et al.
Drug Development Research|August 30, 2016
MicroRNAs as CNS Drug TargetsDavid Gurwitz
Drug Development Research|April 18, 2018
A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitusZhenhai Shang, Feifei Han, Xueyan Zhou, et al.
Drug Development Research|June 30, 2009
EGFR Inhibition in the Treatment of Non-Small Cell Lung CancerDavid E Gerber
Pageof 138